Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gemini Therapeutics Inc (NQ: GMTX ) N/A UNCHANGED Last Price Updated: 3:59 PM EST, Dec 29, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Gemini Therapeutics Inc < Previous 1 2 3 Next > Gemini Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update November 15, 2021 From Gemini Therapeutics, Inc. Via Business Wire Gemini Therapeutics Announces Poster Presentation at AAO 2021 November 12, 2021 From Gemini Therapeutics, Inc. Via Business Wire Gemini Therapeutics to Participate in Upcoming Investor Conferences November 11, 2021 From Gemini Therapeutics, Inc. Via Business Wire Gemini Therapeutics Announces Presentation at 2nd Annual Dry AMD Therapeutic Development Summit October 19, 2021 From Gemini Therapeutics, Inc. Via Business Wire The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline August 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business August 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... Via Benzinga Gemini Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) October 14, 2021 From Gemini Therapeutics, Inc. Via Business Wire Gemini Axes Chief Scientific Officer, 20% Of Staff To Focus On Geographic Atrophy Candidate October 05, 2021 Gemini Therapeutics Inc (NASDAQ: GMTX) announced a corporate restructuring, including several executive officer transitions, prioritizing assets, and focusing on GEM103'... Via Benzinga Gemini Therapeutics Announces Corporate Restructuring to Prioritize Late-Stage Clinical Development of GEM103 for Geographic Atrophy October 05, 2021 From Gemini Therapeutics, Inc. Via Business Wire Gemini Therapeutics Announces Presentation of Preclinical Data at the 13th International Conference on Complement Therapeutics September 10, 2021 From Gemini Therapeutics, Inc. Via Business Wire The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal July 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout October 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session September 09, 2021 Gainers IVERIC bio (NASDAQ:ISEE) shares ... Via Benzinga Gemini Therapeutics Announces Presentation of Previously Released Data from Its Ongoing Phase 2a Study of GEM103 at EURETINA 2021 Virtual September 09, 2021 From Gemini Therapeutics, Inc. Via Business Wire Gemini Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference September 07, 2021 From Gemini Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session August 31, 2021 Gainers Sonnet BioTherapeutics (NASDAQ:SONN Via Benzinga 55 Biggest Movers From Yesterday September 01, 2021 Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it... Via Benzinga Gemini Therapeutics Announces Presentation of Previously Released Data from Its Ongoing Phase 2a Study of GEM103 at Clinical Trials at the Summit August 30, 2021 From Gemini Therapeutics, Inc. Via Business Wire The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data August 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... Via Benzinga Exposures COVID-19 Gemini Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update August 12, 2021 From Gemini Therapeutics, Inc. Via Business Wire Gemini Therapeutics to Participate in the H.C. Wainwright Ophthalmology Conference August 10, 2021 From Gemini Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session August 06, 2021 Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The market value of their outstanding shares is at $1.... Via Benzinga Stocks That Hit 52-Week Lows On Friday July 30, 2021 On Friday morning, 33 companies hit new 52-week lows. Areas of Significance: The largest company in terms of market cap to set a new 52-week low was Las Vegas Sands... Via Benzinga The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings August 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts July 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... Via Benzinga The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study July 16, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's After-Market Session July 15, 2021 Gainers Akebia Therapeutics (NASDAQ:AKBA... Via Benzinga The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO July 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs July 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,... Via Benzinga Topics Product Recall Exposures Legal Product Safety The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test July 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... Via Benzinga Topics Product Recall Exposures COVID-19 Legal Product Safety < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
